HealthStream (NASDAQ:HSTM) Director Sells $50,000.00 in Stock

HealthStream director Linda Rebrovick sold 2,000 shares on June 1 at an average $25.00, for $50,000, according to an SEC filing. After the sale, she owned 54,181 shares. The trade followed a Rule 10b5-1 plan. Separately, HealthStream reported May 4 quarterly EPS of $0.20 on $81.2M revenue and authorized a $10M buyback.

Original reporting
Published Jun 3, 2026, 7:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 7:51 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
HealthStream (NASDAQ:HSTM) Director Sells $50,000.00 in Stock — source image
Decision brief

The 30-second read

$HSTMNeutralLow
01

Why it matters

Trading focus is on whether the insider sale changes sentiment despite being pre-planned; the fundamental backdrop includes a recent earnings beat and an active repurchase authorization.

02

Market read

For HSTM, this is a low-signal insider transaction with limited fundamental implications, but it can influence very short-term sentiment around the stock.

03

What to watch

The article also cites a recent earnings beat, dividend payment, and $10m repurchase authorization—these may offset any negative optics from the director sale.

Relevance 6/10Novelty 4/10Timing: pre-market/early-session context following the June 1 sale disclosure

Background

The piece centers on an SEC-disclosed director sale (2,000 shares) executed under a pre-arranged Rule 10b5-1 trading plan, plus a snapshot of recent earnings, buyback authorization, and dividend.

Company-level read

Ticker impact

$HSTMNeutralMedium confidence
Context

HealthStream director Linda Rebrovick sold 2,000 shares at ~$25 under a Rule 10b5-1 plan, disclosed via SEC filing.

Expected impact

Low-to-moderate near-term sentiment drag; likely limited fundamental impact unless follow-on selling accelerates.

Evidence & confidence

The article provides a specific Form 4-style sale size/price and confirms Rule 10b5-1 pre-arrangement, reducing the likelihood of a new negative fundamental catalyst.

Market effects

Limited read-through for healthcare LMS/workforce training peers; this is company-specific insider activity rather than sector regulation or contract news.

None material beyond US small/mid-cap sentiment.

None.

Counterpoint

Rule 10b5-1 sales can coincide with routine liquidity needs; the more actionable signal may be the company’s ongoing buyback authorization and recent earnings beat.

Key entities

  • HealthStream, Inc.

    NASDAQ-listed provider of healthcare workforce development and learning management solutions; subject of the director sale and recent corporate actions.

  • Linda Rebrovick

    HealthStream director who sold 2,000 shares at an average ~$25 under a Rule 10b5-1 plan.

Related articles

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.